Tetsuro Oishi

1.9k total citations
95 papers, 1.3k citations indexed

About

Tetsuro Oishi is a scholar working on Reproductive Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Tetsuro Oishi has authored 95 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Reproductive Medicine, 24 papers in Surgery and 24 papers in Molecular Biology. Recurrent topics in Tetsuro Oishi's work include Ovarian cancer diagnosis and treatment (35 papers), Endometrial and Cervical Cancer Treatments (22 papers) and Cervical Cancer and HPV Research (10 papers). Tetsuro Oishi is often cited by papers focused on Ovarian cancer diagnosis and treatment (35 papers), Endometrial and Cervical Cancer Treatments (22 papers) and Cervical Cancer and HPV Research (10 papers). Tetsuro Oishi collaborates with scholars based in Japan, United States and France. Tetsuro Oishi's co-authors include Junzo Kigawa, Hiroaki Itamochi, Naoki Terakawa, Muneaki Shimada, Shinya Sato, Yasunobu Kanamori, Tasuku Harada, Seiya Sato, Jun Naniwa and Michiko Nonaka and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Tetsuro Oishi

89 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tetsuro Oishi Japan	22	568	428	356	218	199	95	1.3k
Dana M. Roque United States	20	348 0.6×	266 0.6×	480 1.3×	201 0.9×	69 0.3×	61	1.1k
Shu Liao United States	15	667 1.2×	271 0.6×	262 0.7×	300 1.4×	68 0.3×	23	1.4k
Takashi Mitamura Japan	20	428 0.8×	259 0.6×	192 0.5×	347 1.6×	53 0.3×	59	1.0k
Huimin Bai China	17	326 0.6×	341 0.8×	263 0.7×	272 1.2×	57 0.3×	52	907
Nobuhisa Yoshikawa Japan	18	266 0.5×	384 0.9×	253 0.7×	209 1.0×	39 0.2×	91	980
Mauricio Cuello Chile	25	984 1.7×	249 0.6×	823 2.3×	265 1.2×	111 0.6×	72	2.4k
Chiao‐Yun Lin Taiwan	18	410 0.7×	124 0.3×	151 0.4×	106 0.5×	50 0.3×	71	822
Daniel Guimarães Tiezzi Brazil	17	267 0.5×	103 0.2×	488 1.4×	86 0.4×	128 0.6×	77	1.1k
Margaret Tonda United States	16	339 0.6×	256 0.6×	370 1.0×	82 0.4×	110 0.6×	45	1.3k
Salvatore Pisconti Italy	22	502 0.9×	94 0.2×	692 1.9×	56 0.3×	154 0.8×	97	1.7k

Countries citing papers authored by Tetsuro Oishi

Since Specialization

Citations

This map shows the geographic impact of Tetsuro Oishi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuro Oishi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuro Oishi more than expected).

Fields of papers citing papers by Tetsuro Oishi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuro Oishi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuro Oishi. The network helps show where Tetsuro Oishi may publish in the future.

Co-authorship network of co-authors of Tetsuro Oishi

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuro Oishi. A scholar is included among the top collaborators of Tetsuro Oishi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuro Oishi. Tetsuro Oishi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kawabata‐Iwakawa, Reika, Kenichi Satoh, Jacques Colinge, et al.. (2024). Prediction of response to promising first-line chemotherapy in ovarian cancer patients with residual peritoneal tumors: practical biomarkers and robust multiplex models. International Journal of Clinical Oncology. 29(9). 1334–1346.

Kitao, Shinichiro, et al.. (2021). Amide proton transfer imaging in differentiation of type II and type I endometrial carcinoma: a pilot study. Japanese Journal of Radiology. 40(2). 184–191. 13 indexed citations

Komatsu, Hiroaki, et al.. (2021). Re-classification of uterine cervical cancer cases treated with radical hysterectomy based on the 2018 FIGO staging system. Taiwanese Journal of Obstetrics and Gynecology. 60(6). 1054–1058. 10 indexed citations

Hasegawa, Kosei, Muneaki Shimada, Satoshi Takeuchi, et al.. (2020). A phase 2 study of intraperitoneal carboplatin plus intravenous dose-dense paclitaxel in front-line treatment of suboptimal residual ovarian cancer. British Journal of Cancer. 122(6). 766–770. 4 indexed citations

Nagao, Shoji, Tetsuro Oishi, Satoshi Yamaguchi, et al.. (2020). Phase II study of a new multidisciplinary therapy using once every 3 week carboplatin plus dose-dense weekly paclitaxel before and after radical hysterectomy for locally advanced cervical cancer. International Journal of Clinical Oncology. 26(1). 207–215. 9 indexed citations

Kitagawa, Ryo, Mitsuya Ishikawa, Taro Shibata, et al.. (2018). A randomized phase II/III trial of conventional paclitaxel and carboplatin (cTC) versus dose-dense paclitaxel and carboplatin (ddTC), with or without bevacizumab (Bmab), for stage IVb, recurrent, or persistent cervical cancer (CC): Japan Clinical Oncology Group study (JCOG1311).. Journal of Clinical Oncology. 36(15_suppl). TPS5603–TPS5603. 1 indexed citations

Deura, Imari, Muneaki Shimada, Seiya Sato, et al.. (2014). Incidence and risk factors for lower limb lymphedema after gynecologic cancer surgery with initiation of periodic complex decongestive physiotherapy. International Journal of Clinical Oncology. 20(3). 556–560. 45 indexed citations

Shimada, Muneaki, Seiya Sato, Imari Deura, et al.. (2013). Outcome of stage IB2–IIB patients with bulky uterine cervical cancer who underwent neoadjuvant chemotherapy followed by radical hysterectomy. International Journal of Clinical Oncology. 19(2). 348–353. 14 indexed citations

Itamochi, Hiroaki, Mayumi Nishimura, Tetsuro Oishi, et al.. (2013). Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA gene. Human Cell. 26(3). 121–127. 12 indexed citations

10.

Itamochi, Hiroaki, Mayumi Nishimura, Tetsuro Oishi, et al.. (2012). Establishment and characterization of a novel ovarian serous adenocarcinoma cell line, TU-OS-4, that overexpresses EGFR and HER2. Human Cell. 25(4). 111–115. 5 indexed citations

11.

Itamochi, Hiroaki, Junzo Kigawa, Yasunobu Kanamori, et al.. (2007). Adenovirus type 5 E1A gene therapy for ovarian clear cell carcinoma: a potential treatment strategy. Molecular Cancer Therapeutics. 6(1). 227–235. 21 indexed citations

12.

Oishi, Tetsuro, Hiroaki Itamochi, Junzo Kigawa, et al.. (2007). Galectin-3 may contribute to Cisplatin resistance in clear cell carcinoma of the ovary. International Journal of Gynecological Cancer. 17(5). 1040–1046. 34 indexed citations

13.

Naniwa, Jun, Junzo Kigawa, Yasunobu Kanamori, et al.. (2006). Genetic diagnosis for chemosensitivity with drug-resistance genes in epithelial ovarian cancer. International Journal of Gynecological Cancer. 17(1). 76–82. 30 indexed citations

14.

Kanamori, Yasunobu, Junzo Kigawa, Jun Naniwa, et al.. (2005). PTEN-positive and phosphorylated-Akt-negative expression is a predictor of survival for patients with advanced endometrial carcinoma. Oncology Reports. 14(2). 389–92. 52 indexed citations

15.

Shimada, Muneaki, Junzo Kigawa, Yasunobu Kanamori, et al.. (2005). Outcome of patients with early ovarian cancer undergoing three courses of adjuvant chemotherapy following complete surgical staging. International Journal of Gynecological Cancer. 15(4). 601–605. 8 indexed citations

16.

Kigawa, Junzo, Yasunobu Kanamori, Hiroaki Itamochi, et al.. (2004). Expression of the c‐myc gene as a predictor of chemotherapy response and a prognostic factor in patients with ovarian cancer. Cancer Science. 95(5). 418–423. 41 indexed citations

17.

Naniwa, Jun, Junzo Kigawa, Yasunobu Kanamori, et al.. (2003). Leptomycin B enhances CDDP‐sensitivity via nuclear accumulation of p53 protein in HPV‐positive cells. Cancer Science. 94(12). 1099–1103. 11 indexed citations

18.

Oishi, Tetsuro, Junzo Kigawa, Keiichi Fujiwara, et al.. (2003). A feasibility study on biweekly administration of docetaxel for patients with recurrent ovarian cancer☆. Gynecologic Oncology. 90(2). 421–424. 11 indexed citations

19.

Mori, Toshio, Nobuaki Kobayashi, Tetsuro Oishi, et al.. (1996). [A case of double cancer, cholangiocellular and hepatocellular carcinoma associated with autoimmune hepatitis].. PubMed. 93(12). 915–20. 2 indexed citations

20.

Oishi, Tetsuro, et al.. (1993). [Acute cerebellar ataxia with sympathotonic orthostatic hypotension following Epstein-Barr virus infection--a case report].. PubMed. 33(5). 503–6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact